Results 171 to 180 of about 1,599,144 (366)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Central Nervous System Guides Different Impairments Regarding Some Dysmetabolic Diseases [PDF]

Anna Piro
openalex   +1 more source

Metabolic associated fatty liver disease is a disease related to sympathetic nervous system activation

, 2022
Zhao-Chun Chi
openalex   +1 more source

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

Microphysiological Systems for Neurodegenerative Diseases in Central Nervous System. [PDF]

Micromachines (Basel), 2020
Bae M, Yi HG, Jang J, Cho DW.
europepmc   +1 more source

Advances in the Application of Susceptibility-Weighted Imaging (SWI) in Central Nervous System Diseases [PDF]

栩毅 全
openalex   +1 more source

Central Nervous System Sequelae in Patients with Coronavirus Disease 19

, 2022
Mohamed O. Alhamad, Saud A. Alkhlofi, Taha S. AbuIdrees, Aysha M. Ahmed, Salman K. Taheri, Reem A. Alrowaiei, Mariam Lafi Ali, Ghada Al‐Kafaji, Haitham Jahrami, Ahmed S. BaHammam   +9 more
openalex   +1 more source

Gene transfer to the nervous system: prospects for novel treatments directed at diseases of the aging nervous system.

The journals of gerontology. Series A, Biological sciences and medical sciences, 2003
M. Mata, J. Glorioso, D. Fink
semanticscholar   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source

Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases [PDF]

, 2022
Jie Tong, Baosheng Chen, Peng Wen Tan, Stephen Kurpiewski, Zhengxin Cai   +4 more
openalex   +1 more source